Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Faex Health Announces Investigational AI Screening Capabilities for Ebola and H. pylori, Expanding Gut Health Platform to 18 Conditions

      Faex Health, a digital health company that has developed AI-powered tools to help people better understand and track digestive wellness, has been selected as a 2026 Top Innovator at the New York Venture Summit, taking place at the Javits Center in New York City through Nov. 19.

      News provided by

      Faex Health

      Nov 20, 2026, 15:26 ET

      Share this article

      Share this article


      Unveiled during HITLAB's Center for AI Testing and Evidence program, the new capabilities aim to identify potential health warning signs through smartphone images of stool, without laboratory testing for the initial assessment

      NEW YORK, Nov. 20, 2026 /PRNewswire/ -- Faex Health, a digital health company that has developed AI-powered tools to help people better understand and track digestive wellness, announced the addition of Ebola virus disease and Helicobacter pylori (H. pylori) to its investigational pre-screening platform, expanding its internally validated panel to 18 gastrointestinal and related health conditions. The announcement was made by Faex Health Co-Founder and CEO Landon Nattrass during a virtual presentation hosted by HITLAB's Center for AI Testing and Evidence (CAITE).

      The two new indications represent a significant expansion of Faex Health's research into how artificial intelligence and computer vision can identify potential health warning signs through photographs of human stool. Using a standard smartphone camera, the platform analyzes visual characteristics, including color, consistency, texture, blood, mucus, and other anomalies, to generate preliminary health indicators that may warrant further medical evaluation.

      While H. pylori and Ebola present dramatically different public health challenges, both underscore the potential value of accessible, noninvasive health monitoring, particularly in communities where traditional diagnostic infrastructure may be limited or difficult to access.

      "From one of the world's most widespread bacterial infections to one of its most dangerous viral diseases, H. pylori and Ebola illustrate the extraordinary range of public health challenges Faex Health is working to address," Nattrass said. "By expanding our investigational platform to include both conditions, we are exploring how technology people already carry in their pockets could help bridge gaps in health monitoring, particularly where access to traditional testing is limited."

      Addressing Two Distinct Global Health Challenges

      H. pylori, a bacterial infection affecting approximately half of the world's population, is a major cause of peptic ulcer disease and an established risk factor for gastric cancer. Many infected individuals experience no symptoms, making identification and treatment particularly challenging. Conventional testing typically requires a urea breath test, stool antigen test, or endoscopic biopsy.

      Faex Health's newly announced H. pylori indication is designed to explore whether AI analysis of stool images can provide an accessible preliminary signal that encourages appropriate follow-up testing and medical evaluation. Ebola virus disease, by contrast, is a rare but potentially fatal infectious disease that can cause severe gastrointestinal symptoms, including diarrhea and significant fluid loss. Confirmatory diagnosis requires specialized laboratory testing, typically using reverse transcription polymerase chain reaction (RT-PCR).

      Faex Health is investigating whether visual patterns in stool could contribute to preliminary triage assessments in outbreak environments, particularly where laboratory resources are limited or delays in testing may complicate public health response. The technology is not intended to diagnose Ebola or replace established laboratory testing, infection-control procedures or clinical assessment. Both new indications have undergone internal validation using Faex Health's proprietary datasets. Neither has entered clinical trials, and neither has received U.S. Food and Drug Administration (FDA) clearance or approval.

      Expanding AI-Powered Monitoring Across 18 Health Conditions

      With the addition of Ebola and H. pylori, Faex Health's investigational platform now encompasses 18 conditions across five clinical categories, including infectious diseases; colorectal and gastrointestinal bleeding conditions; chronic and inflammatory disorders; functional and anorectal conditions; and hepatic, pancreatic and microbiome-related conditions.

      The panel includes investigational indicators associated with colorectal cancer risk, precancerous polyps, Crohn's disease, ulcerative colitis, irritable bowel syndrome, celiac disease, gastrointestinal bleeding, and other digestive health concerns.

      Unlike traditional stool testing methods that capture information at a single point in time, Faex Health is designed to support ongoing monitoring through repeated smartphone images. Its computer vision technology evaluates stool characteristics consistently over time, creating the potential to identify changes and patterns that may otherwise go unrecorded. The platform also provides Bristol Stool Form Scale classifications and evaluates seven categories of visual anomalies.

      "Your gut produces information about your health every day, yet most of that information is never captured or evaluated," Nattrass added. "Our vision is to make monitoring those changes as routine as checking your heart rate or tracking your sleep. Rather than relying exclusively on isolated tests, we believe longitudinal data could eventually provide healthcare professionals and individuals with a more complete picture of digestive health."

      Advancing Clinical Research and Commercial Deployment

      Faex Health's broader research program includes the ongoing FECAL-AI clinical trial at Hospital Dr. Sótero del Río in Chile, where investigators are evaluating the platform's image-derived signals in colorectal cancer screening against conventional fecal immunochemical testing (FIT).

      The company is also exploring the design of a larger-scale colorectal cancer screening study in the United Kingdom involving the National Health Service (NHS) and National Institute for Health and Care Research (NIHR). That proposed program remains in the planning stage and has not received protocol approval.

      Commercially, Faex Health reports four signed agreements representing approximately 150,000 covered lives, with its first 50,000 covered lives active as of November 2026. Beyond its current 18-condition investigational panel, Faex Health is conducting exploratory research into stool-visible indicators associated with more than 100 additional health conditions. Nattrass will further discuss the company's research, clinical development and vision for AI-powered health monitoring at the HITLAB Innovators Summit on Dec. 3 at the Microsoft Technology Center in Times Square, New York City.

      For more information or to schedule an interview, contact Shawna Seldon at [email protected] or +1 917-971-7852.

      About Faex Health
      Faex Health is a health technology company that has developed AI-powered solutions for preventive gastrointestinal health monitoring. Using computer vision, machine learning, and smartphone-based image analysis, the Faex platform helps users capture digestive health information, monitor patterns over time, and access personalized educational wellness insights. The company has developed solutions designed to support individuals, healthcare providers, health plans, employers, and population health organizations. Faex Health's investigational clinical applications are intended to complement established medical screening and diagnostic pathways, not replace them. For more information, visit FaexHealth.com. Download the Faex Health app on Apple Store for iOS and Google Play for Android. Continue the conversation on LinkedIn, Facebook, TikTok, X, Reddit, and Instagram.

      Regulatory and Clinical Research Disclosure: Faex Health is investigational and has not received FDA clearance or approval. Its outputs are preliminary pre-screening indicators intended for health awareness and professional review, not medical diagnoses. All 18 indications have undergone internal validation, but these findings have not been independently replicated or peer reviewed as a complete panel. Clinical trials have not begun for the Ebola or H. pylori indications. The platform is not a substitute for laboratory testing, established screening protocols or professional medical evaluation.

      SOURCE Faex Health

      Modal title

      Also from this source

      Faex Health Named 2026 New York Venture Summit Top Innovator

      Faex Health Named 2026 New York Venture Summit Top Innovator

      Faex Health, a digital health company that has developed AI-powered tools to help people better understand and track digestive wellness, has been...

      Faex Health Brings AI-Powered Digestive Health Monitoring to HLTH 2026, Advancing the Conversation Around Preventive Healthcare

      Faex Health Brings AI-Powered Digestive Health Monitoring to HLTH 2026, Advancing the Conversation Around Preventive Healthcare

      Faex Health, a digital health company that has developed AI-powered tools to help people better understand and track digestive wellness, is...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Computer & Electronics

      Computer & Electronics

      Artificial Intelligence

      Artificial Intelligence

      Clinical Trials & Medical Discoveries

      Clinical Trials & Medical Discoveries

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.